Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Day One Biopharmaceuticals Inc (DAWN)

Day One Biopharmaceuticals Inc (DAWN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
7.74 -0.16 (-2.03%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 7.74 unch (unch) 16:26 ET
Quote Overview for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
7.61
Day High
7.85
Open 7.79
Previous Close 7.90 7.90
Volume 729,000 729,000
Avg Vol 1,130,185 1,130,185
Stochastic %K 85.71% 85.71%
Weighted Alpha -48.45 -48.45
5-Day Change +0.90 (+13.16%) +0.90 (+13.16%)
52-Week Range 6.41 - 18.07 6.41 - 18.07
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 731,776
  • Shares Outstanding, K 101,354
  • Annual Sales, $ 131,160 K
  • Annual Income, $ -95,500 K
  • EBIT $ -217 M
  • EBITDA $ -215 M
  • 60-Month Beta -1.24
  • Price/Sales 5.98
  • Price/Cash Flow N/A
  • Price/Book 1.55

Options Overview Details

View History
  • Implied Volatility 99.93% ( -68.90%)
  • Historical Volatility 65.54%
  • IV Percentile 86%
  • IV Rank 46.58%
  • IV High 204.16% on 04/16/25
  • IV Low 9.07% on 08/12/24
  • Put/Call Vol Ratio 0.11
  • Today's Volume 21
  • Volume Avg (30-Day) 78
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 4,684
  • Open Int (30-Day) 6,699

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.46
  • Number of Estimates 5
  • High Estimate -0.33
  • Low Estimate -0.73
  • Prior Year -0.72
  • Growth Rate Est. (year over year) +36.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.41 +20.75%
on 04/09/25
Period Open: 8.28
8.29 -6.63%
on 03/28/25
-0.54 (-6.52%)
since 03/25/25
3-Month
6.41 +20.75%
on 04/09/25
Period Open: 12.21
13.53 -42.79%
on 01/28/25
-4.47 (-36.61%)
since 01/24/25
52-Week
6.41 +20.75%
on 04/09/25
Period Open: 13.21
18.07 -57.17%
on 05/01/24
-5.47 (-41.41%)
since 04/25/24

Most Recent Stories

More News
Day One to Report First Quarter 2025 Financial Results Tuesday, May 6, 2025

DAWN : 7.74 (-2.03%)
Day One Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Progress

DAWN : 7.74 (-2.03%)
Day One to Report Fourth Quarter and Full-Year 2024 Financial Results Tuesday, February 25, 2025

DAWN : 7.74 (-2.03%)
Day One Reports Preliminary 2024 OJEMDAâ„¢ Net Product Revenue and Highlights 2025 Corporate Priorities

DAWN : 7.74 (-2.03%)
3 Beaten-Down Biotech Stocks to Buy for a Turnaround in 2025

The biotech sector witnessed a see-saw performance in 2024. Though the year started on a positive note, those gains were erased in the second half due to disappointing third-quarter results, guidance cuts,...

ALLO : 1.5500 (-1.27%)
IMCR : 30.16 (-0.66%)
DAWN : 7.74 (-2.03%)
Day One to Present at the 43rd Annual J.P. Morgan Healthcare Conference

DAWN : 7.74 (-2.03%)
Day One Announces Retirement of Dr. Samuel Blackman, Co-Founder and Head of Research & Development

DAWN : 7.74 (-2.03%)
Day One to Participate in the Piper Sandler 36th Annual Healthcare Conference

DAWN : 7.74 (-2.03%)
Day One Biopharmaceuticals (DAWN) Stock Soars 11.3% on Strategic Milestones and Promising Outlook

Shares of Day One Biopharmaceuticals (NASDAQ: DAWN) surged 11.3% this morning, reflecting strong investor confidence fueled by a series of favorable developments. This biotech firm focused on advancing...

DAWN : 7.74 (-2.03%)
Day One Reports Third Quarter 2024 Financial Results and Corporate Progress

DAWN : 7.74 (-2.03%)

Business Summary

Day One Biopharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It dedicated to developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Day One Biopharmaceuticals Inc. is based in SOUTH SAN FRANCISCO, Calif.

See More

Key Turning Points

3rd Resistance Point 8.10
2nd Resistance Point 7.97
1st Resistance Point 7.86
Last Price 7.74
1st Support Level 7.62
2nd Support Level 7.49
3rd Support Level 7.38

See More

52-Week High 18.07
Fibonacci 61.8% 13.62
Fibonacci 50% 12.24
Fibonacci 38.2% 10.86
Last Price 7.74
52-Week Low 6.41

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective